Trio Face 11 Year Wait On Eliquis As US Patents Upheld

Key Formulation Patent Stands Strong Against Attack From Three Firms

 
• By Dean Rudge
  
Gavel
Sunshine Lake, Sigmapharm and Unichem went against the groove in taking their cases to trial • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin